These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34521217)

  • 1. Outcomes of Participants With Diabetes in the ISCHEMIA Trials.
    Newman JD; Anthopolos R; Mancini GBJ; Bangalore S; Reynolds HR; Kunichoff DF; Senior R; Peteiro J; Bhargava B; Garg P; Escobedo J; Doerr R; Mazurek T; Gonzalez-Juanatey J; Gajos G; Briguori C; Cheng H; Vertes A; Mahajan S; Guzman LA; Keltai M; Maggioni AP; Stone GW; Berger JS; Rosenberg YD; Boden WE; Chaitman BR; Fleg JL; Hochman JS; Maron DJ
    Circulation; 2021 Oct; 144(17):1380-1395. PubMed ID: 34521217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity.
    Reynolds HR; Shaw LJ; Min JK; Page CB; Berman DS; Chaitman BR; Picard MH; Kwong RY; O'Brien SM; Huang Z; Mark DB; Nath RK; Dwivedi SK; Smanio PEP; Stone PH; Held C; Keltai M; Bangalore S; Newman JD; Spertus JA; Stone GW; Maron DJ; Hochman JS
    Circulation; 2021 Sep; 144(13):1024-1038. PubMed ID: 34496632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival After Invasive or Conservative Management of Stable Coronary Disease.
    Hochman JS; Anthopolos R; Reynolds HR; Bangalore S; Xu Y; O'Brien SM; Mavromichalis S; Chang M; Contreras A; Rosenberg Y; Kirby R; Bhargava B; Senior R; Banfield A; Goodman SG; Lopes RD; Pracoń R; López-Sendón J; Maggioni AP; Newman JD; Berger JS; Sidhu MS; White HD; Troxel AB; Harrington RA; Boden WE; Stone GW; Mark DB; Spertus JA; Maron DJ;
    Circulation; 2023 Jan; 147(1):8-19. PubMed ID: 36335918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial.
    Lopes RD; Alexander KP; Stevens SR; Reynolds HR; Stone GW; Piña IL; Rockhold FW; Elghamaz A; Lopez-Sendon JL; Farsky PS; Chernyavskiy AM; Diaz A; Phaneuf D; De Belder MA; Ma YT; Guzman LA; Khouri M; Sionis A; Hausenloy DJ; Doerr R; Selvanayagam JB; Maggioni AP; Hochman JS; Maron DJ
    Circulation; 2020 Nov; 142(18):1725-1735. PubMed ID: 32862662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney Function.
    Bangalore S; Hochman JS; Stevens SR; Jones PG; Spertus JA; O'Brien SM; Reynolds HR; Boden WE; Fleg JL; Williams DO; Stone GW; Sidhu MS; Mathew RO; Chertow GM; Maron DJ
    JAMA Cardiol; 2022 Aug; 7(8):825-835. PubMed ID: 35767253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons.
    Chaitman BR; Alexander KP; Cyr DD; Berger JS; Reynolds HR; Bangalore S; Boden WE; Lopes RD; Demkow M; Piero Perna G; Riezebos RK; McFalls EO; Banerjee S; Bagai A; Gosselin G; O'Brien SM; Rockhold FW; Waters DD; Thygesen KA; Stone GW; White HD; Maron DJ; Hochman JS;
    Circulation; 2021 Feb; 143(8):790-804. PubMed ID: 33267610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
    ; Maron DJ; Hochman JS; O'Brien SM; Reynolds HR; Boden WE; Stone GW; Bangalore S; Spertus JA; Mark DB; Alexander KP; Shaw L; Berger JS; Ferguson TB; Williams DO; Harrington RA; Rosenberg Y
    Am Heart J; 2018 Jul; 201():124-135. PubMed ID: 29778671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial.
    Reynolds HR; Cyr DD; Merz CNB; Shaw LJ; Chaitman BR; Boden WE; Alexander KP; Rosenberg YD; Bangalore S; Stone GW; Held C; Spertus J; Goetschalckx K; Bockeria O; Newman JD; Berger JS; Elghamaz A; Lopes RD; Min JK; Berman DS; Picard MH; Kwong RY; Harrington RA; Thomas B; O'Brien SM; Maron DJ; Hochman JS;
    J Am Heart Assoc; 2024 Mar; 13(5):e029850. PubMed ID: 38410945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial.
    Pracoń R; Spertus JA; Broderick S; Bangalore S; Rockhold FW; Ruzyllo W; Demchenko E; Nageh T; Grossman GB; Mavromatis K; Manjunath CN; Smanio PEP; Stone GW; Mancini GBJ; Boden WE; Newman JD; Reynolds HR; Hochman JS; Maron DJ;
    Circ Cardiovasc Interv; 2024 Jun; 17(6):e013435. PubMed ID: 38629312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial.
    Bangalore S; Spertus JA; Stevens SR; Jones PG; Mancini GBJ; Leipsic J; Reynolds HR; Budoff MJ; Hague CJ; Min JK; Boden WE; O'Brien SM; Harrington RA; Berger JS; Senior R; Peteiro J; Pandit N; Bershtein L; de Belder MA; Szwed H; Doerr R; Monti L; Alfakih K; Hochman JS; Maron DJ;
    Circ Cardiovasc Interv; 2022 Apr; 15(4):e010925. PubMed ID: 35411785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA-CKD.
    Briguori C; Mathew RO; Huang Z; Mavromatis K; Hickson LJ; Lau WL; Mathew A; Mahajan S; Wheeler DC; Claes KJ; Chen G; Nolasco FEB; Stone GW; Fleg JL; Sidhu MS; Rockhold FW; Chertow GM; Hochman JS; Maron DJ; Bangalore S
    J Am Heart Assoc; 2022 Mar; 11(6):e022003. PubMed ID: 35261290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era.
    Fanning JP; Nyong J; Scott IA; Aroney CN; Walters DL
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004815. PubMed ID: 27226069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA.
    McGuire DK; Alexander JH; Johansen OE; Perkovic V; Rosenstock J; Cooper ME; Wanner C; Kahn SE; Toto RD; Zinman B; Baanstra D; Pfarr E; Schnaidt S; Meinicke T; George JT; von Eynatten M; Marx N;
    Circulation; 2019 Jan; 139(3):351-361. PubMed ID: 30586723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction.
    Chaitman BR; Hardison RM; Adler D; Gebhart S; Grogan M; Ocampo S; Sopko G; Ramires JA; Schneider D; Frye RL;
    Circulation; 2009 Dec; 120(25):2529-40. PubMed ID: 19920001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial.
    Chaitman BR; Cyr DD; Alexander KP; Pracoń R; Bainey KR; Mathew A; Acharya A; Kunichoff DF; Fleg JL; Lopes RD; Sidhu MS; Anthopolos R; Rockhold FW; Stone GW; Maron DJ; Hochman JS; Bangalore S
    Circ Cardiovasc Interv; 2022 Aug; 15(8):e012103. PubMed ID: 35973009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction.
    Furtado RHM; Bonaca MP; Raz I; Zelniker TA; Mosenzon O; Cahn A; Kuder J; Murphy SA; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Ruff CT; Nicolau JC; Gause-Nilsson IAM; Fredriksson M; Langkilde AM; Sabatine MS; Wiviott SD
    Circulation; 2019 May; 139(22):2516-2527. PubMed ID: 30882239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial.
    Dangas GD; Farkouh ME; Sleeper LA; Yang M; Schoos MM; Macaya C; Abizaid A; Buller CE; Devlin G; Rodriguez AE; Lansky AJ; Siami FS; Domanski M; Fuster V;
    J Am Coll Cardiol; 2014 Sep; 64(12):1189-97. PubMed ID: 25236509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Brooks MM; Chaitman BR; Nesto RW; Hardison RM; Feit F; Gersh BJ; Krone RJ; Sako EY; Rogers WJ; Garber AJ; King SB; Davidson CJ; Ikeno F; Frye RL;
    Circulation; 2012 Oct; 126(17):2115-24. PubMed ID: 23008442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial Invasive or Conservative Strategy for Stable Coronary Disease.
    Maron DJ; Hochman JS; Reynolds HR; Bangalore S; O'Brien SM; Boden WE; Chaitman BR; Senior R; López-Sendón J; Alexander KP; Lopes RD; Shaw LJ; Berger JS; Newman JD; Sidhu MS; Goodman SG; Ruzyllo W; Gosselin G; Maggioni AP; White HD; Bhargava B; Min JK; Mancini GBJ; Berman DS; Picard MH; Kwong RY; Ali ZA; Mark DB; Spertus JA; Krishnan MN; Elghamaz A; Moorthy N; Hueb WA; Demkow M; Mavromatis K; Bockeria O; Peteiro J; Miller TD; Szwed H; Doerr R; Keltai M; Selvanayagam JB; Steg PG; Held C; Kohsaka S; Mavromichalis S; Kirby R; Jeffries NO; Harrell FE; Rockhold FW; Broderick S; Ferguson TB; Williams DO; Harrington RA; Stone GW; Rosenberg Y;
    N Engl J Med; 2020 Apr; 382(15):1395-1407. PubMed ID: 32227755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.